Shirley Bachman
Vice President, US Market Access
Alnylam Pharmaceuticals
Shirley Bachman
Alnylam is committed to our Patient Access Philosophy. It is the foundation for everything we do. We strive for an innovative approach with payers through our Value Based Framework and close collaboration.
In addition to leadership responsibilities in strategy development, payer marketing, pricing, contracting, and contract operations; Shirley manages Alnylam’s National Account organization. This organization is responsible for US payer partnerships for both National and Regional accounts. Shirley joined Alnylam in 2017 and was part of the launch of the company’s first RNAi therapeutic in 2018 for payer markets.
Shirley has over 25 years of experience in sales, channel, account team, and organizational leadership for US payers and Specialty Pharmacy markets, and strategy development for immunology, oncology, and rare disease categories. Prior to Alnylam, Shirley managed organizations for Medivation and Johnson and Johnson, respectively. Shirley holds a BS, Marketing degree, College of Charleston, South Carolina.
Shirley has over 25 years of experience in sales, channel, account team, and organizational leadership for US payers and Specialty Pharmacy markets, and strategy development for immunology, oncology, and rare disease categories. Prior to Alnylam, Shirley managed organizations for Medivation and Johnson and Johnson, respectively. Shirley holds a BS, Marketing degree, College of Charleston, South Carolina.
